chloroquine has been researched along with Measles in 5 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
Measles: A highly contagious infectious disease caused by MORBILLIVIRUS, common among children but also seen in the nonimmune of any age, in which the virus enters the respiratory tract via droplet nuclei and multiplies in the epithelial cells, spreading throughout the MONONUCLEAR PHAGOCYTE SYSTEM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The immune response of 198 young Nigerian children protected against malaria by chemoprophylaxis with chloroquine to immunization with triple, poliomyelitis, measles, typhoid, meningococcal and BCG vaccines was compared with the immune response to vaccination of 185 control children." | 9.05 | Malaria chemoprophylaxis with chloroquine in young Nigerian children. II. Effect on the immune response to vaccination. ( Bartlett, A; Bidwell, DE; Bradley, AK; Bradley-Moore, AM; Craske, J; Gilles, HM; Greenwood, BM; Kirkwood, BR; Voller, A, 1985) |
| "The immune response of 198 young Nigerian children protected against malaria by chemoprophylaxis with chloroquine to immunization with triple, poliomyelitis, measles, typhoid, meningococcal and BCG vaccines was compared with the immune response to vaccination of 185 control children." | 5.05 | Malaria chemoprophylaxis with chloroquine in young Nigerian children. II. Effect on the immune response to vaccination. ( Bartlett, A; Bidwell, DE; Bradley, AK; Bradley-Moore, AM; Craske, J; Gilles, HM; Greenwood, BM; Kirkwood, BR; Voller, A, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakazibwe, C | 1 |
| Greenwood, BM | 2 |
| van Binnendijk, RS | 1 |
| Poelen, MC | 1 |
| Kuijpers, KC | 1 |
| Osterhaus, AD | 1 |
| Uytdehaag, FG | 1 |
| Cénac, A | 1 |
| Develoux, M | 1 |
| Djibo, A | 1 |
| Bradley-Moore, AM | 1 |
| Bradley, AK | 1 |
| Bartlett, A | 1 |
| Bidwell, DE | 1 |
| Voller, A | 1 |
| Craske, J | 1 |
| Kirkwood, BR | 1 |
| Gilles, HM | 1 |
1 trial available for chloroquine and Measles
| Article | Year |
|---|---|
Malaria chemoprophylaxis with chloroquine in young Nigerian children. II. Effect on the immune response to vaccination.
Topics: Antibody Formation; BCG Vaccine; Child, Preschool; Chloroquine; Diphtheria; Humans; Immunity, Cellul | 1985 |
4 other studies available for chloroquine and Measles
| Article | Year |
|---|---|
Treating malaria at home in Uganda.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Caregivers; Chloroquine; Dev | 2006 |
Chloroquine prophylaxis and antibody response to immunisation.
Topics: Antibody Formation; Chloroquine; Humans; Immunization; Infant; Malaria; Measles; Polysaccharides, Ba | 1984 |
The predominance of CD8+ T cells after infection with measles virus suggests a role for CD8+ class I MHC-restricted cytotoxic T lymphocytes (CTL) in recovery from measles. Clonal analyses of human CD8+ class I MHC-restricted CTL.
Topics: Antigen-Presenting Cells; Antigens, Differentiation, T-Lymphocyte; Antigens, Viral; CD8 Antigens; Ch | 1990 |
Chloroquine treatment of malaria does not increase antibody response to measles vaccination. A controlled study of 580 rural children living in an endemic malaria area.
Topics: Animals; Antibodies, Viral; Child, Preschool; Chloroquine; Humans; Infant; Malaria; Measles; Measles | 1988 |